A Company Undercut That CEO Who Raised The Price Of A Vital Drug By Over 4,000%

Imprimis Pharmaceuticals claims it can make a close, customized version of the drug for $1 a pill.

Last month, Martin Shkreli, the 32-year-old founder of Turing Pharmaceuticals, provoked global outrage after raising the price of a drug used to treat AIDS and cancer patients from $13.50 to $750 per pill overnight.

Last month, Martin Shkreli, the 32-year-old founder of Turing Pharmaceuticals, provoked global outrage after raising the price of a drug used to treat AIDS and cancer patients from $13.50 to $750 per pill overnight.

Bloomberg / Getty Images

The drug, Daraprim, is used to treat parasitic infections known as toxoplasmosis. His decision meant that patients could expect to face thousands of dollars in treatment costs.

 

Shkreli’s company purchased the rights to the drug in August. At the time, he defended his decision, saying it was “necessary to make a profit” on the drug so he could invest in research to develop new versions of it.

Shkreli’s company purchased the rights to the drug in August. At the time, he defended his decision, saying it was “necessary to make a profit” on the drug so he could invest in research to develop new versions of it.

Bloomberg / Getty Images


View Entire List ›

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s